3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
8
INDUSTRY
6
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Dermatologic
1
Conditions
Melanoma
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Interferon-alpha
6
Radiosurgery
4
Dacarbazine
4
encorafenib
3
binimetinib
3
aldesleukin
3
Radiotherapy
3
Methotrexate
3
Immunohistochemistry
3
Gene Expression Profiling
3
Filgrastim
3
Etoposide
3
Cyclophosphamide
3
Cisplatin
3
Watchful Waiting
2
Vincristine
2
Vinblastine
2
Temozolomide
2
Polymerase Chain Reaction
2
Nivolumab
2
Ipilimumab
2
Introns
2
Interferon alpha-2
2
Immunologic Techniques
2
Flow Cytometry
2
Carboplatin
2
trametinib
1
tebentafusp
1
sulforaphane
1
sargramostim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Immune Checkpoint Inhibitors
×
Dermatologic
×
Clear all
NCT05522660
2026-04-27
USZ-STRIKE
ETOP IBCSG Partners Foundation
Phase 3
Recruiting
180 enrolled